No Data
No Data
Jiaying Pharmaceutical (002198.SZ) announced first-quarter results, net profit of 5.1822 million yuan, a decrease of 57.47%
Jiaying Pharmaceutical (002198.SZ) released its report for the first quarter of 2024, achieving 944 operating income during the reporting period...
Express News | Jiaying Pharmaceutical: Plans to invest no more than 15 million yuan to build a new production workshop for Gujing ginseng and antler pills
Jiaying Pharmaceutical (002198.SZ): As of January 19, 2024, the number of shareholders of the company was 24,225
Gelonghui, January 23 | Jiaying Pharmaceutical (002198.SZ) said on the investor interactive platform that as of January 19, 2024, according to the shareholder register issued by Zhongdeng, the number of shareholders of the company was 24,225.
Jiaying Pharmaceutical (002198.SZ): As of January 10, 2024, the number of shareholders of the company was 24,572
Gelonghui, January 11 | Jiaying Pharmaceutical (002198.SZ) said on the investor interactive platform that as of January 10, 2024, according to the shareholder register issued by Zhongdeng, the number of shareholders of the company was 24,572.
Jiaying Pharmaceutical (002198.SZ): Downstream customers are mainly pharmaceutical commercial companies, pharmacy chains, hospitals, etc.
Gelonghui, December 11丨Jiaying Pharmaceutical (002198.SZ) said on the investor interactive platform that the company's downstream customers are mainly pharmaceutical commercial companies, pharmacy chains and hospitals.
Jiaying Pharmaceutical (002198.SZ): It plans to invest no more than 32 million yuan in the construction of plants and supporting facilities
On December 8, Gelonghui丨Jiaying Pharmaceutical (002198.SZ) announced that the company plans to invest in the construction of plants and supporting facilities based on the company's future strategic development plan, creating the possibility for the company to achieve greater revenue sources while considering the company's current situation. The total construction investment is estimated to be no more than 32 million yuan.
No Data